Hologic Clarity HD+® Imaging Technology

    Overview

    Training

    Fastest, Highest Resolution 3D™ Images. Compared to other standard models.1*

    Unleash the power of the fastest and highest resolution 3D images in the industry with the same 70-micron pixel size as FFDM. The Clarity HD high-resolution 3D imaging's breakthrough detector and advanced 3D imaging algorithm work together to deliver exceptional 3D images – regardless of breast size or density.23456

    More Clarity.

    More Confidence.

    • Accelerate screening and analysis

    • Designed to clearly see subtle lesions and fine calcifications to help pinpoint cancers early

    • Designed to help you diagnose patients with greater certainty

    Get a Head Start on Identifying Invasive Breast Cancer

    High-Resolution Images

    Create high-resolution 3D™ images with any breast size reconstructed at 70-micron pixel size.

    Detects More

    Detects 20-65% more invasive breast cancers compared to 2D mammography alone.2

    Reduces Recalls

    Reduces recalls by up to 40% compared to 2D alone.2345

    2X Resolution

    Generates images with 2X the tomosynthesis resolution of the standard 3D Mammography™ exam.

    Improved Visualization

    Produce sharper, less noisy images for improved visualization of fine calcifications compared to other standard models.1

    Higher Contrast Images

    Take advantage of higher contrast images, skin-line improvements, and minimal artifacts. Compared to other standard models.1

    Product Gallery

    Placeholder
    Placeholder
    Placeholder

    Get in Touch

    Need Support?

    For help with orders, relocation, or technical and application support.

    Clarity HD high-resolution 3D™ imaging is standard with all 3Dimensions™ systems, and is available as an optional upgrade for existing Selenia® Dimensions® systems. The Clarity HD high-resolution 3D™ imaging is a prerequisite for Intelligent 2D™ imaging technology. The Genius™ 3D Mammography™ exam (a.k.a. Genius™ exam) is acquired on the Hologic® 3D Mammography™ system and consists of a 2D and 3D™ image set, where the 2D image can be either an acquired 2D image or a 2D image generated from the 3D™ image set. The Genius™ exam is only available on the Hologic® 3D Mammography™ system.
    Hologic, 3D, 3D Mammography, 3Dimensions, Affirm, C-View, Dimensions, I-View, Intelligent 2D, MammoPad, SecurView, Selenia, SmartCurve, Quantra, The Science of Sure and associated logos are trademarks and/or registered trademarks of Hologic, Inc., and/or its subsidiaries in the United States and/or other countries. This information is intended for medical professionals in the U.S. and other markets and is not intended as a product solicitation or promotion where such activities are prohibited. Because Hologic materials are distributed through websites, eBroadcasts and tradeshows, it is not always possible to control where such materials appear. For specific information on what products are available for sale in a particular country, please contact your local Hologic representative.
    © 2022 Hologic, Inc. All Rights Reserved.
    References: 
    1. Rocha Garcia, A.M., Mera Fernandez, D.  Breast tomosynthesis: State of the art. Radiologia. 2019;61(4):274-285  2. Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014 Jun 25;311(24):2499-507. 3. Zuckerman SP, Conant EF, Keller BM, et al. Implementation of Synthesized Two-dimensional Mammography in a Population-based Digital Breast Tomosynthesis Screening Program. Radiology. 2016 Dec; 281(3):730-736. 4. Skaane P, Bandos A, Eben EB, et al. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images. Radiology. 2014 Jun; 271(3):655-63. 5.Bernardi D, Macaskill P, Pellegrini M, et al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13. 6. McDonald ES, Oustimov A, Weinstein SP, et al. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening. JAMA Oncol. 2016 Jun 1;2(6):737 43.